Circulating Tumor Cells Patent Landscape and Forecast 2024-2032 - The U.S. Leads with Over 4,000 Patent Filings, Driven by Robust R&D Infrastructure and Substantial Investments in Cancer D...
IDEX Corporation (IEX)
Last idex corporation earnings: 4/23 04:02 pm
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=83305&p=irol-irhome
Company Research
Source: Yahoo! Finance
The circulating tumor cells market was valued at USD 11.5 billion in 2023. It is expected to grow at a CAGR of 12.5% during the forecast period of 2024-2032 and attain a market value of USD 33.2 billion in 2032. Advancements in microfluidic technologies and increasing demand for non-invasive cancer diagnostics are driving robust patent activity in circulating tumor cells isolation and detection. The patent analysis report for the microfluidics landscape provides a comprehensive overview of the latest technological advancements and strategic patent holdings within the industry. It covers innovations across key areas such as lab-on-a-chip technologies, diagnostic applications, and drug delivery systems. The report includes detailed insights into market trends, regulatory environments, and potential growth opportunities. It also highlights key players and their patent portfolios, examining the impact of collaborative research efforts and increasing R&D investments on patent activities
Show less
Read more
Impact Snapshot
Event Time:
IEX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IEX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IEX alerts
High impacting IDEX Corporation news events
Weekly update
A roundup of the hottest topics
IEX
News
- Advanced At-home Biomarker Testing Market USD 2,255.7 Million Growth Forecast Period 2024 to 2034 Comprehensive Analysis and Growth Forecast at a CAGR of 7.5% | FMI [Yahoo! Finance]Yahoo! Finance
- IDEX Corporation Declares Regular Quarterly Cash DividendBusiness Wire
- Auburn University researchers hard at work pioneering energy-related advancements of future [Yahoo! Finance]Yahoo! Finance
- Here's Why SouthernSun SMID Cap Investment Strategy Exited IDEX Corporation (IEX) [Yahoo! Finance]Yahoo! Finance
- IDEX Co. (NYSE: IEX) had its price target raised by analysts at Royal Bank of Canada from $236.00 to $248.00. They now have an "outperform" rating on the stock.MarketBeat
IEX
Earnings
- 10/29/24 - Beat
IEX
Sec Filings
- 10/30/24 - Form 10-Q
- 10/30/24 - Form 8-K
- 10/7/24 - Form SC
- IEX's page on the SEC website